Inhibition of aldose reductase in vitro by constituents of Ganoderma lucidum

Planta Medica

Volumn 76, Issue 15, 2010, Pages 1691-1693

  Fatmawati, Sri ^a,b   Shimizu, Kuniyoshi ^a   Kondo, Ryuichiro ^a  

^a KYUSHU UNIVERSITY   (Japan)

^b DEPARTMENT OF ELECTRICAL ENGINEERING   (Indonesia)

Author keywords

aldose reductase inhibitor; ganoderic acid; Ganoderma lucidum; Ganodermataceae; triterpenoid

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; GANODERENIC ACID A; GANODERIC ACID; GANODERIC ACID C2; GANODERMA LUCIDUM EXTRACT; METHYL GANODERATE A; METHYL GANODERATE C2; METHYL GANODERENATE A; QUERCETIN; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG INHIBITION; DRUG ISOLATION; DRUG STRUCTURE; GANODERMA LUCIDUM; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; IC 50; IN VITRO STUDY;

GANODERMA LUCIDUM; GANODERMATACEAE;

EID: 77958579745     PISSN: 00320943     EISSN: 14390221     Source Type: Journal    
DOI: 10.1055/s-0030-1249782     Document Type: Article

References (22)

1. Young R J., Ewing D J., Clarke B F. A controlled trial of sorbinil, an aldose reductase inhibitor, in chronic painful diabetic neuropathy. Diabetes 1983 32 938-942
2. Dunlop M. Aldose reductase and the role of the polyol pathway in diabetic nephropathy. Kidney Int Suppl 2000 77 S3-S12
3. Frank R N., Keirn R J., Kennedy A, Frank K W. Galactose induced retinal capillary basement membrane thickening, prevention by sorbinil. Invest Opthalmol Vis Sci 1983 24 1519-1524
4. Robinson Jr W G., Nagata M, Laver N, Hohman T C., Kinoshita J H. Diabetic-like retinopathy in rats prevented with an aldose reductase inhibitor. Invest Opthalmol Vis Sci 1989 30 2285-2292
5. Bhatnagar A, Srivastava S K. Aldose reductase: congenial and injurious profiles of an enigmatic enzyme. Biochem Med Metab Biol 1992 48 91-121
6. Patterson R R. M. Ganoderma a theraupetic fungal biofactory. Phytochemistry 2006 67 1985-2001
7. Fatmawati S, Kurashiki K, Takeno S, Kim Y, Shimizu K, Sato M, Imaizumi K, Takahashi K, Kamiya S, Kaneko S, Kondo R. The inhibitory effect on aldose reductase by an extract of Ganoderma lucidum. Phytother Res 2009 23 28-32
8. Hikino H, Konno C, Mirin Y, Hayashi T. Isolation and hypoglycemic activity of ganoderans A and B, glycans of Ganoderma lucidum fruit bodies. Planta Med 1985 51 339-340
9. Min B S., Gao J J., Hattori M, Lee H K., Kim Y H. Anticomplement activity of terpenoids from the spores of Ganoderma lucidum. Planta Med 2001 67 811-814
10. Ha T B. T., Gerhäuser C, Zhang W D., Ho-Chong-Line N, Fourasté I. New lanostanoids from Ganoderma lucidum that induce NAD(P)H:Quinone oxidoreductase in cultured hepalclc7 murine hepatoma cells. Planta Med 2000 66 681-684
11. Koyama K, Imaizumi K, Akiba M, Kinoshita K, Takahashi K, Suzuki A, Yano S, Horie S, Watanabe K, Naoi Y. Antinociceptive components of Ganoderma lucidum. Planta Med 1997 63 224-227
12. Liu J, Shiono J, Shimizu K, Kondo R. Ganoderic acids from Ganoderma lucidum: inhibitory activity of osteoclastic differentiation and structural criteria. Planta Med
13. Gao J J., Nakamura N, Min B S., Hirakawa A, Zuo F, Hattori M. Quantitative determination of bitter principles in specimens of Ganoderma lucidum using high-performance liquid chromatography and its application to the evaluation of Ganoderma products. Chem Pharm Bull 2004 52 688-695
14. Ma J, Ye Q, Hua Y, Zhang D, Cooper R, Chang M N., Chang J Y., Sun H H. New lanostanoids from the mushroom Ganoderma lucidum. J Nat Prod 2002 65 72-75
15. Lee S H., Shim S H., Kim J S., Shin K H., Kang S S. Aldose reductase inhibitors from the fruiting bodies of Ganoderma applanatum. Biol Pharm Bull 2005 28 1103-1105
16. Lee S H., Shim S H., Kim J S., Kang S S. Constituents from the fruiting bodies of Ganoderma applanatum and their aldose reductase inhibitory activity. Arch Pharm Res 2006 29 479-483
17. Urzhumtsev A, Favier F T., Mitschler A, Barbanton J, Barth P, Urzhumtseva L, Biellmann J F., Podjarny A D., Moras D. A specificity' pocket inferred from the crystal structures of the complexes of aldose reductase with the pharmaceutically important inhibitors tolrestat and sorbinil. Structure 1997 5 601-612
18. Wang X, Liu R, Sun J, Guan S, Yang M, Bi K, Guo D. HPLC method for the determination and pharmacokinetic studies of four triterpenoids in rat plasma after oral administration of Ganoderma lucidum extract. Biomed Chromatogr 2007 21 389-396 (Pubitemid 46567198)
19. Kikuchi T, Kanomi S, Kadota S, Murai Y, Tsubono K, Ogita Z. Constituents of the fungus Ganoderma lucidum (Fr.) Karst. I. Structures of ganoderic acid C2, E, I, and K, lucidenic acid F and related compounds. Chem Pharm Bull 1986 34 3695-3712
20. Komoda Y, Nakamura H, Ishihara S, Uchida M, Kohda H, Yamazaki K. Structures of new terpenoid constituents of Ganoderma lucidum (Fr.) Karst (Polyporaceae). Chem Pharm Bull 1985 33 4829-4835 (Pubitemid 16181320)
21. Kubota T, Asaka Y, Miura I, Mori H. Structures of ganoderic acid A and B, two new lanostane type bitter triterpenes from Ganoderma lucidum (Fr.) Karst. Helv Chim Act 1982 62 611-619
22. Nishimura C, Yamaoka T, Mizutani M, Yamashita K, Akera T, Tanimoto T. Purification and characterization of the recombinant human aldose reductase expressed in baculovirus system. Biochim Biophys Act 1991 1078 171-178